Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19

Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19

Abstract Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including cytokines but also several therapeutic d...

Full description

Bibliographic Details
Main Authors: Paul Biever, Dawid L. Staudacher, Michaela J. Sommer, Hannah Triebel, Merja A. Neukamm, Christoph Bode, Alexander Supady, Achim Lother
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Pharmacology Research & Perspectives
Subjects:
COVID‐19
cytokine
hemoadsorption
remdesivir
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/prp2.743

Internet

https://doi.org/10.1002/prp2.743

Similar Items